NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18 | -28.0% | 25,310 | +130.1% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 11,000 | -1.8% | 0.00% | – |
| Q3 2022 | $36,000 | -21.7% | 11,201 | -7.7% | 0.00% | – |
| Q2 2022 | $46,000 | +666.7% | 12,141 | +964.1% | 0.00% | – |
| Q1 2022 | $6,000 | -97.0% | 1,141 | -93.6% | 0.00% | -100.0% |
| Q4 2021 | $198,000 | -35.5% | 17,805 | +4.3% | 0.00% | -50.0% |
| Q3 2021 | $307,000 | -43.6% | 17,077 | -46.1% | 0.00% | -33.3% |
| Q2 2021 | $544,000 | -32.0% | 31,697 | -20.8% | 0.00% | -40.0% |
| Q1 2021 | $800,000 | +38.4% | 39,997 | +17.6% | 0.01% | +25.0% |
| Q4 2020 | $578,000 | +21.9% | 33,997 | +19.0% | 0.00% | 0.0% |
| Q3 2020 | $474,000 | -45.8% | 28,580 | -24.2% | 0.00% | -50.0% |
| Q2 2020 | $874,000 | +140.1% | 37,716 | +84.8% | 0.01% | +100.0% |
| Q1 2020 | $364,000 | +49.2% | 20,413 | +80.4% | 0.00% | +100.0% |
| Q4 2019 | $244,000 | +38.6% | 11,313 | +17.0% | 0.00% | 0.0% |
| Q3 2019 | $176,000 | -92.5% | 9,670 | -85.4% | 0.00% | -90.9% |
| Q2 2019 | $2,359,000 | +35.9% | 66,300 | +28.3% | 0.02% | +29.4% |
| Q1 2019 | $1,736,000 | +182.7% | 51,658 | +176.7% | 0.02% | +142.9% |
| Q4 2018 | $614,000 | -82.6% | 18,669 | -67.8% | 0.01% | -78.1% |
| Q3 2018 | $3,531,000 | +704.3% | 57,924 | +543.6% | 0.03% | +540.0% |
| Q2 2018 | $439,000 | -85.4% | 9,000 | -68.1% | 0.01% | -83.9% |
| Q1 2018 | $2,997,000 | +5776.5% | 28,200 | +3217.6% | 0.03% | +3000.0% |
| Q4 2017 | $51,000 | +155.0% | 850 | 0.0% | 0.00% | – |
| Q3 2017 | $20,000 | +17.6% | 850 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | -15.0% | 850 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | 0.0% | 850 | -46.9% | 0.00% | – |
| Q4 2016 | $20,000 | -25.9% | 1,600 | 0.0% | 0.00% | – |
| Q3 2016 | $27,000 | +17.4% | 1,600 | 0.0% | 0.00% | – |
| Q2 2016 | $23,000 | +4.5% | 1,600 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |